Raymond Townsend is Director at Kindred Biosciences, Inc. (KIN). They have made 7 open-market trades across 1 company since 2013, most recently 2021-08-27.
CIK 0001593867
5 open-market purchases totalling $68K since 2013, against 2 sales. Across 5 scored buys the stock is up 8.2% at ninety days, and 9.4 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| KIN | 27,813 | $257K |
Shares reported on the most recent Form 4, priced at the 2018-09-27 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -3.8% | +2.6% | +8.2% |
| Alpha | +2.0% | +2.4% | +9.4% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KIN | SELL | 2018-09-25 | 2018-09-27 | $13.32 | $40K | -7.9% | -12.2% | -20.4% |
| KIN | SELL · 10b5-1 | 2018-03-15 | 2018-03-19 | $9.45 | $25K | -2.3% | +5.6% | +18.6% |
| KIN | SELL · 10b5-1 | 2018-03-12 | 2018-03-14 | $9.45 | $860 | -3.2% | -1.6% | +13.4% |
| KIN | SELL | 2018-01-02 | 2018-01-04 | $9.45 | $121K | -4.9% | -16.3% | -9.2% |
| KIN | BUY | 2015-11-23 | 2015-11-24 | $4.00 | $8K | -3.8% | +2.6% | +18.7% |
| KIN | BUY | 2015-11-18 | 2015-11-19 | $4.78 | $11K | -3.8% | +2.6% | +14.3% |
| KIN | BUY | 2015-08-31 | 2015-09-01 | $5.85 | $10K | -3.8% | +2.6% | +2.6% |
| KIN | BUY | 2015-08-14 | 2015-08-17 | $6.04 | $18K | -3.8% | +2.6% | +2.6% |
| KIN | BUY | 2013-12-12 | 2013-12-13 | $7.00 | $21K | -3.8% | +2.6% | +2.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.